This information sheet provides general information about hepatitis A. It explains the disease; provides statistics on hepatitis occurrence in the United States; and discusses at-risk persons, transmission, symptoms, diagnosis, and treatment. It promotes the usage of vaccine as the best method of preventing the disease and lists persons who should get vaccinated against hepatitis A.

This information sheet provides information about AIDS Drug Assistance Programs (ADAPs). It discusses ADAP budgets, expenditures, formularies, clients, eligibility criteria, cost containment measures, waiting lists, drug purchasing models, insurance purchasing, and medicare.

This video details how common hepatitis B is and the dangers associated with it. It says that one in twenty people have been exposed to hepatitis B and that most people don't know they have it. The video also says that hepatitis B is the 3rd most common cause of death from cancer in males, and the 7th most common in females. It also describes the history of the Hepatitis B Foundation and how the organization is working to finding a cure, improving the lives of those living with hepatitis B, and eliminating the disease.

This information sheet discusses hepatitis C. It explains the purpose of the liver, the seriousness of hepatitis C, its transmission, symptoms, why an individual needs to be tested for hepatitis C, what blood tests are used to diagnose the disease, what happens if an individual tests positive, prevention, and sources of more information.

This journal article is a practice guideline that provides recommendations summarizing the growing literature and current best practices of chronic Hepatitis C Virus (HCV) treatment, including treatment in difficult-to-treat populations. These recommendations are based on an extensive review of published data, national consensus recommendations, and input from thought leaders involved in HCV care and treatment.